(Q36646958)

15 August 2017

1 reference

title

The medical management of opioid dependence in HIV primary care settings (English)

1 reference

15 August 2017

Paula J Lum

1

1 reference

15 August 2017

Jacqueline Peterson Tulsky

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

15 August 2017

published in

Current HIV/AIDS reports

1 reference

15 August 2017

volume

3

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

195-204

1 reference

Policy progress for physician treatment of opiate addiction

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Heroin: new facts about an old myth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Tuberculosis in drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

21 January 2018

Acute heroin overdose

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Methadone maintenance and the likelihood of risky needle-sharing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

New federal initiatives to enhance the medical treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

The animal pharmacology of buprenorphine, an oripavine analgesic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

The Clinical Opiate Withdrawal Scale (COWS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Acute pain management for patients receiving maintenance methadone or buprenorphine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Integrating medical care and addiction treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-006-0016-Z

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

21 January 2018

1 reference

12 December 2020

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments

1 reference

12 December 2020

A controlled trial of buprenorphine treatment for opioid dependence

1 reference

12 December 2020

Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs

1 reference

12 December 2020

The reduction of intravenous heroin use, non-opiate abuse and crime during methadone maintenance treatment: further findings

1 reference

12 December 2020

Neurobiology of addictive behaviors and its relationship to methadone maintenance

1 reference

12 December 2020

Major increases in opioid analgesic abuse in the United States: concerns and strategies

1 reference

12 December 2020

The effect of HIV infection on overdose mortality.

1 reference

12 December 2020

Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome

1 reference

12 December 2020

Six deaths linked to concomitant use of buprenorphine and benzodiazepines

1 reference

12 December 2020

Medical education about substance abuse: changes in curriculum and faculty between 1976 and 1992.

1 reference

12 December 2020

Effect of opioid dependence pharmacotherapies on zidovudine disposition

1 reference

12 December 2020

Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing

1 reference

12 December 2020

Models for integrating buprenorphine therapy into the primary HIV care setting

1 reference

12 December 2020

Neuroscience of addiction

1 reference

12 December 2020

Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet

1 reference

12 December 2020

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

1 reference

12 December 2020

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

1 reference

12 December 2020

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

1 reference

12 December 2020

A prospective study of mortality among drug misusers during a 4-year period after seeking treatment

1 reference

12 December 2020

HIV seroconversion in intravenous drug users in San Francisco, 1985-1990.

1 reference

12 December 2020

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

12 December 2020

Reductions in criminal convictions after addiction treatment: 5-year follow-up

1 reference

12 December 2020

Sublingual buprenorphine is effective in the treatment of chronic pain syndrome

1 reference

12 December 2020

Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction

1 reference

12 December 2020

Bacterial infections in drug users

1 reference

12 December 2020

Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine

1 reference

12 December 2020

Consensus statement on office-based treatment of opioid dependence using buprenorphine

1 reference

12 December 2020

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

1 reference

12 December 2020

Explaining the geographical variation of HIV among injection drug users in the United States

1 reference

12 December 2020

Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes

1 reference

12 December 2020

Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors

1 reference

12 December 2020

From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States

1 reference

12 December 2020

The undertreatment of pain in ambulatory AIDS patients

1 reference

12 December 2020

Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users

1 reference

12 December 2020

Hepatitis after intravenous buprenorphine misuse in heroin addicts

1 reference

12 December 2020

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence

1 reference

12 December 2020

Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART

1 reference

12 December 2020

Drug dependence: stress and dysregulation of brain reward pathways

1 reference

12 December 2020

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

1 reference

12 December 2020

Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients

1 reference

12 December 2020

Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.

1 reference

12 December 2020

Outpatient patterns of care and longitudinal intensity of antiretroviral therapy for HIV-infected drug users

1 reference

12 December 2020

Wound botulism associated with black tar heroin among injecting drug users

1 reference

12 December 2020

Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up

1 reference

12 December 2020

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

1 reference

12 December 2020

Professional satisfaction experienced when caring for substance-abusing patients: faculty and resident physician perspectives

1 reference

12 December 2020

Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes

1 reference

12 December 2020

Buprenorphine: a primer for emergency physicians

1 reference

12 December 2020

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

1 reference

12 December 2020

Self-reported antiretroviral therapy in injection drug users.

1 reference

12 December 2020

Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment

1 reference

12 December 2020

Acute hepatitis due to buprenorphine administration

1 reference

12 December 2020

A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway

1 reference

12 December 2020

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

1 reference

12 December 2020

Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users

1 reference

12 December 2020

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

1 reference

12 December 2020

Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study

1 reference

12 December 2020

Treating opioid dependence. Growing implications for primary care

1 reference

12 December 2020

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

1 reference

12 December 2020

The quantification of mortality resulting from the regular use of illicit opiates.

1 reference

12 December 2020

The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States

1 reference

12 December 2020

Methadone and buprenorphine added to the WHO list of essential medicines

1 reference

12 December 2020

Molecular and cellular basis of addiction

1 reference

12 December 2020

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

1 reference

12 December 2020

Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone

1 reference

12 December 2020

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions

1 reference

12 December 2020

Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users

1 reference

12 December 2020

Deaths attributable to methadone vs buprenorphine in France

1 reference

12 December 2020

Effects of buprenorphine/naloxone in opioid-dependent humans

1 reference

12 December 2020

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice

1 reference

12 December 2020

Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders

1 reference

12 December 2020

Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

1 reference

12 December 2020

10.1007/S11904-006-0016-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference